Document is current
Any future updates will be listed below
-
Authors
Dedeilia, Aikaterini
Lwin, Thinzar
Li, Siming
Tarantino, Giuseppe
Tunsiricharoengul, Sasha
Lawless, Aleigha
Sharova, Tatyana
Liu, David
Boland, Genevieve M.
Cohen, Sonia
-
Funding
Funding for this research was provided by:
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Harvard Medical School (George)
Harvard Medical School (Marie Vergottis Postdoctoral Fellowship)
Huiying Foundation (Patricia K. Donahoe Award)
Harvard Catalyst (National Institutes of Health Award KL2 TR002542)
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 20 November 2023
First Online: 29 December 2023
Disclosure
: Dr. Genevieve Boland discloses the following financial and professional collaborations:Takeda Oncology: sponsored research agreement, Olink Proteomics: sponsored research agreement, Novartis: scientific advisory board, speaker, Nektar Therapeutics: scientific advisory board, steering committee, Palleon Pharmaceuticals: sponsored research agreement, InterVenn Biosciences: sponsored research agreement, scientific advisory board, Merck: scientific advisory board, consulting, Iovance: scientific advisory board, Ankyra Therapeutics: scientific advisory board, equity.All other authors have no conflicts of interest to disclose.
